Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.
2.

Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein.

Glenner GG, Wong CW.

Biochem Biophys Res Commun. 1984 Aug 16;122(3):1131-5.

PMID:
6236805
3.

Different processing of Alzheimer's beta-protein precursor in the vessel wall of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type.

Prelli F, Castaño EM, van Duinen SG, Bots GT, Luyendijk W, Frangione B.

Biochem Biophys Res Commun. 1988 Mar 30;151(3):1150-5.

PMID:
3281669
4.

Amyloid angiopathy of Alzheimer's disease: amino acid composition and partial sequence of a 4,200-dalton peptide isolated from cortical microvessels.

Pardridge WM, Vinters HV, Yang J, Eisenberg J, Choi TB, Tourtellotte WW, Huebner V, Shively JE.

J Neurochem. 1987 Nov;49(5):1394-401.

PMID:
3312495
5.

Amyloid beta protein and the basis for Alzheimer's disease.

Glenner GG.

Prog Clin Biol Res. 1989;317:857-68. Review.

PMID:
2690126
6.

Differences between vascular and plaque core amyloid in Alzheimer's disease.

Prelli F, Castaño E, Glenner GG, Frangione B.

J Neurochem. 1988 Aug;51(2):648-51.

PMID:
3292706
7.

Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.

Coria F, Castaño E, Prelli F, Larrondo-Lillo M, van Duinen S, Shelanski ML, Frangione B.

Lab Invest. 1988 Apr;58(4):454-8.

PMID:
2965774
8.

N-terminal heterogenicity of amyloid protein examined in Alzheimer's disease.

Pirim I, Erdogan AR, Tan U.

Int J Neurosci. 2004 Jan;114(1):75-81.

PMID:
14660069
9.

Characterization of amyloid fibril beta-peptide in familial Alzheimer's disease with APP717 mutations.

Liepnieks JJ, Ghetti B, Farlow M, Roses AD, Benson MD.

Biochem Biophys Res Commun. 1993 Dec 15;197(2):386-92.

PMID:
8267572
11.

Beta-amyloid precursor protein and early-onset Alzheimer's disease.

Hendriks L, Jonghe CDXs, Cras P, Martin JJ, Broeckhoven CV.

Ciba Found Symp. 1996;199:170-80.

PMID:
8915610
12.

Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses.

Snow AD, Wight TN.

Neurobiol Aging. 1989 Sep-Oct;10(5):481-97. Review.

PMID:
2682326
13.

Human brain pericytes as a model system to study the pathogenesis of cerebrovascular amyloidosis in Alzheimer's disease.

Verbeek MM, Otte-Höller I, Ruiter DJ, de Waal RM.

Cell Mol Biol (Noisy-le-grand). 1999 Feb;45(1):37-46.

PMID:
10099838
14.
15.

High-resolution separation of amyloid beta-peptides: structural variants present in Alzheimer's disease amyloid.

Näslund J, Karlström AR, Tjernberg LO, Schierhorn A, Terenius L, Nordstedt C.

J Neurochem. 1996 Jul;67(1):294-301.

PMID:
8667005
16.

Beta-amyloid: Alzheimer's disease and brain beta-amyloidoses.

Koudinova NV, Berezov TT, Koudinov AR.

Biochemistry (Mosc). 1999 Jul;64(7):752-7. Review.

PMID:
10424897
17.

Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. 1984.

Glenner GG, Wong CW.

Biochem Biophys Res Commun. 2012 Aug 31;425(3):534-9. doi: 10.1016/j.bbrc.2012.08.020. No abstract available.

PMID:
22925670
18.

Detection of novel proteins associated with secondary amyloidosis and Alzheimer's disease by monoclonal antibody.

Yamashita T, Imai K, Saito N, Yachi A.

Brain Res. 1988 Dec 6;474(2):309-15.

PMID:
3208135
19.

Neuritic plaque amyloid in Alzheimer's disease is highly racemized.

Shapira R, Austin GE, Mirra SS.

J Neurochem. 1988 Jan;50(1):69-74.

PMID:
3121789
Items per page

Supplemental Content

Write to the Help Desk